Credit: Dr. Ming-Jun Li Talk by one of the leading lights in optical communica...
“UPR [unfolded protein response] modulation in combination with conventional che...
Foodservice companies have long struggled with the challenge of what to do with ...
The absolute internal quantum efficiency (IQE) of indium gallium nitride (InGaN)...
Infections caused by fungi, such as Candida albicans, pose a significant global ...
Expectant mothers and fathers are being failed by the UK Government’s “outdated”...
University of Cincinnati researchers are presenting abstracts at the European St...
Massachusetts-based biotech Moderna has shared results from its early clinical t...
The $300 million series A raised by ReNAgade Therapeutics has been surpassed by ...
The review of a highly anticipated gene therapy for Duchenne muscular dystrophy ...
Novo Nordisk has announced that an oral form of semaglutide, the medication mark...
M&A activity for pharma CMOs reached a peak in 2021, with 2022 seeing a slight d...
Rinvoq is expected to have a rapid uptake in the CD market by healthcare provide...
VANFLYTA was first approved as a monotherapy in the relapsed/refractory setting.
The NDA included data from the Phase III FRESCO-2 and FRESCO trials conducted in...
A few weeks after Covid-19 emergency declaration ended, the FDA has approved Pax...
